ES2179846T3 - Timo de xenoinjerto. - Google Patents
Timo de xenoinjerto.Info
- Publication number
- ES2179846T3 ES2179846T3 ES94917424T ES94917424T ES2179846T3 ES 2179846 T3 ES2179846 T3 ES 2179846T3 ES 94917424 T ES94917424 T ES 94917424T ES 94917424 T ES94917424 T ES 94917424T ES 2179846 T3 ES2179846 T3 ES 2179846T3
- Authority
- ES
- Spain
- Prior art keywords
- timo
- donor
- cells
- xenoinjerto
- injert
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Glass Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Prostheses (AREA)
Abstract
LA INVENCION DESCRIBE METODOS PARA REEMPLAZAR LA FUNCION DEL TIMO E INDUCIR LA TOLERANCIA INMUNOLOGICA. LOS METODOS INCLUYEN LA INTRODUCCION DE TEJIDO XENOGENETICO DE TIMO Y LA ADMINISTRACION DE CELULAS MADRE DEL DONANTE EN COMBINACION CON REGIMENES TERAPEUTICOS QUE PROMUEVEN LA ACEPTACION DEL INJERTO Y PROLIFERACION DE LAS CELULAS DEL DONANTE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6294693A | 1993-05-17 | 1993-05-17 | |
US16391293A | 1993-12-07 | 1993-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2179846T3 true ES2179846T3 (es) | 2003-02-01 |
Family
ID=26742900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94917424T Expired - Lifetime ES2179846T3 (es) | 1993-05-17 | 1994-05-16 | Timo de xenoinjerto. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0697876B1 (es) |
JP (1) | JP3553941B2 (es) |
AT (1) | ATE222111T1 (es) |
AU (1) | AU694120B2 (es) |
CA (1) | CA2161797A1 (es) |
DE (1) | DE69431184T2 (es) |
DK (1) | DK0697876T3 (es) |
ES (1) | ES2179846T3 (es) |
PT (1) | PT697876E (es) |
WO (1) | WO1994026285A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ525829A (en) * | 2000-10-13 | 2005-04-29 | Norwood Immunology Ltd | Improvement of graft acceptance by T cell ablation, areactivating the thymus and adminstrating hematopoietic or epithelial stem cells or progenitor cells |
CA2462681A1 (en) * | 2000-10-13 | 2002-04-18 | Monash University | Disease prevention by reactivation of the thymus |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087570A (en) * | 1988-05-10 | 1992-02-11 | Weissman Irving L | Homogeneous mammalian hematopoietic stem cell composition |
-
1994
- 1994-05-16 EP EP94917424A patent/EP0697876B1/en not_active Expired - Lifetime
- 1994-05-16 CA CA002161797A patent/CA2161797A1/en not_active Abandoned
- 1994-05-16 JP JP52579594A patent/JP3553941B2/ja not_active Expired - Fee Related
- 1994-05-16 DE DE69431184T patent/DE69431184T2/de not_active Expired - Fee Related
- 1994-05-16 ES ES94917424T patent/ES2179846T3/es not_active Expired - Lifetime
- 1994-05-16 PT PT94917424T patent/PT697876E/pt unknown
- 1994-05-16 WO PCT/US1994/005528 patent/WO1994026285A1/en active IP Right Grant
- 1994-05-16 DK DK94917424T patent/DK0697876T3/da active
- 1994-05-16 AT AT94917424T patent/ATE222111T1/de not_active IP Right Cessation
- 1994-05-16 AU AU69157/94A patent/AU694120B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO1994026285A1 (en) | 1994-11-24 |
CA2161797A1 (en) | 1994-11-24 |
JP3553941B2 (ja) | 2004-08-11 |
DE69431184D1 (en) | 2002-09-19 |
EP0697876A4 (en) | 1997-09-10 |
DK0697876T3 (da) | 2002-09-09 |
AU694120B2 (en) | 1998-07-16 |
DE69431184T2 (de) | 2003-03-27 |
JPH09500364A (ja) | 1997-01-14 |
EP0697876A1 (en) | 1996-02-28 |
ATE222111T1 (de) | 2002-08-15 |
PT697876E (pt) | 2002-11-29 |
EP0697876B1 (en) | 2002-08-14 |
AU6915794A (en) | 1994-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2170096T3 (es) | Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes. | |
ES2179077T3 (es) | Acido glutamico decarboxilasa clonada. | |
MX9405383A (es) | Imidazo(4,5-c) piridin-4-aminas. | |
AU1049788A (en) | Methods and peptides for the treatment of non-ige-mediated diseases | |
DE3882899D1 (de) | Mehrschicht-kollimator und diesen verwendende vorrichtung. | |
ES290656Y (es) | Dispositivo para recoger y mantener vivos los cultivos del cuerpo del paciente. | |
ES2190447T3 (es) | Pañal desechable. | |
IT8722072A0 (it) | Perossidi aromatici insaturi e loro impiego in terapia e in cosmetica. | |
ES2151607T3 (es) | Factor 12 de crecimiento y de diferenciacion. | |
ES2063767T3 (es) | Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen. | |
ES2057004T3 (es) | N-alcoxialquilamidas de hidroxiacidos y composiciones a base de las mismas para el tratamiento de la piel. | |
ES2179846T3 (es) | Timo de xenoinjerto. | |
DK93390D0 (da) | Ufuldstaendige hepadnavira og cellelinie, der producerer vacciner, samt behandling af leversygdomme og -forstyrrelser | |
MY131599A (en) | Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity | |
ES2063056T3 (es) | Esteres poliaromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen. | |
ES541944A0 (es) | Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables | |
ES2039516T3 (es) | Empleo de los enantiomeros de la propafenona para la obtencion de medicamentos. | |
EP0668771A4 (en) | TREATMENT OF AUTOIMMUNE DISEASES BY TOLERANCE IN CELLS, TISSUES AND ORGANS. | |
IT8619457A0 (it) | Derivati insaturi cicloalifatici, loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica. | |
ES2165366T3 (es) | Procedimientos y composiciones para inhibir la inflamacion mediada por celulas endoteliales y fibrinogeno. | |
Baik et al. | The Biochemical Study on the Specific Activity of Aspartate Aminotransferase Isozyme in the Retinal Tissues of Normal Adult Bovine | |
ES1004391Y (es) | Aparato electronico para la terapia medica y cosmetica. | |
ES2010963A4 (es) | Derivados de n - cicloalkilaminoetilbenzamida, su sintesis y preparacion farmaceutica | |
UY25396A1 (es) | Pañal absorbente y descartable con una doble barrera lateral antidesborde elastizada | |
PT90898A (pt) | Tratamento das doencas reumaticas por regeneracao celular e o dispositivo que a produz |